Autolus Therapeutics plc (AUTL) Q2 2025 Earnings Call Transcript

2025-08-12 16:37:35 ET

Autolus Therapeutics plc (AUTL)

Q2 2025 Earnings Conference Call

August 12 2025, 08:30 AM ET

Company Participants

Amanda Cray - Corporate Participant

Christian Martin Itin - CEO & Director

Robert F. Dolski - Senior VP, CFO & Principal Accounting Officer

Conference Call Participants

Asthika Sarith Goonewardene - Truist Securities, Inc., Research Division

Dingding Shi - Jefferies LLC, Research Division

Gil Joseph Blum - Needham & Company, LLC, Research Division

James John Shin - Deutsche Bank AG, Research Division

Matthew Christopher Phipps - William Blair & Company L.L.C., Research Division

Simon P. Baker - Redburn (Europe) Limited, Research Division

Presentation

Operator

Good day, and thank you for standing by. Welcome to the Autolus Second Quarter 2025 Financial Results Conference Call. [Operator Instructions] Please be advised today's conference is being recorded.

I would now like to hand the conference over to your speaker today, Amanda Cray, Executive Director of Investor Relations. Please go ahead.

Amanda Cray

Thank you, Kevin. Good morning, or good afternoon, everyone, and thank you for joining us on today's call. With me are Chief Executive Officer, Dr. Christian Itin; and Chief Financial Officer, Rob Dolski....

Read the full article on Seeking Alpha

For further details see: